Skip to main content
SpringerLink
Log in

COVID-19-vaccine/nivolumab/pembrolizumab

Autoimmune encephalitis and confusion: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Ser MH, et al. Recurrent autoimmune encephalitis related to immune checkpoint inhibitors. Epileptic Disorders 24: 609-613, No. 3, Jun 2022. Available from: URL: http://doi.org/10.1684/epd.2022.1425

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

COVID-19-vaccine/nivolumab/pembrolizumab. Reactions Weekly 1936, 176 (2022). https://doi.org/10.1007/s40278-022-29373-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-29373-8

Search

Navigation